Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

PerPedes: AI-assisted therapy in stroke rehabilitation

Project description

Improved rehabilitation for stroke

Stroke constitutes a leading cause of disability, with patients having trouble walking or suffering from paralyses. Despite extensive neurorehabilitation, a significant proportion of patients do not regain their mobility, which negatively impacts their quality of life. The EU-funded PerPedes project proposes a robotic device for neurorehabilitation that better mimics the natural movements of a person. Results show faster recovery compared with existing solutions, and scientists aim to include more functionalities to the device. The inclusion of specialised software and personalised therapy features will improve the efficacy of the device and its commercialisation prospects.

Objective

Annually, about 360,000 Europeans need to follow mobility rehabilitation therapy due to stroke in order to fully or partially regain their mobility functions and return to actively participate in society, and this group is growing rapidly. Current neuro-rehabilitation devices present significant limitations to the recovery of patients, such as poor resemblance to anatomic movements, difficult entry into the device and high costs. As a result, mobility rehabilitation can hardly meet today´s expectations and leads to an increasing number of mobility impaired individuals, who have not only lost mobility but also a vital connection to society in the form of work, social activities and sports.
schepp medtech from Graz, Austria, has designed PerPedes, a revolutionary robotic and end-effector-based neuro-rehabilitation device. In its patented and certified design (TÜV, CE) PerPedes applies common robotics technology to overcome the limitations of current systems. Current PerPedes version has been installed in clinics and daily therapy centres in Eurpe and China. To prepare PerPedes for the future, we need to (i) include a combination of new intelligent software and hardware features to support mobility rehabilitation therapy on a personalised level, (ii) prepare the mechatronics system for production, and (iii) optimise the data management system to facilitate patients and therapists.
Main customers of PerPedes are rehabilitation centres and clinics offering mobility rehabilitation. Due to the growing incidence of stroke, annually up to 1 Million new patients are expected to start using these devices, creating a strong growth in demand. PerPedes will be distributed by a network of well-known medtech distributors to ensure successful sales. Successful commercial launch of PerPedes is expected to result in €11.3 Million of annual sales revenues and €4.7 Million of annual profits (ROI 5.7) as well as the creation of 22 new jobs by 2024.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SCHEPP MEDTECH GMBH
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
PARKRING 2
8712 NIKLASDORF
Austria

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Südösterreich Steiermark Östliche Obersteiermark
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0